U.S. Pharmaceuticals & Biotech Most Popular Stocks

AVITA Medical

Market Cap: US$160.1m

Operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom.

vTv Therapeutics

Market Cap: US$158.9m

A clinical stage biopharmaceutical company, focuses on the development of orally administered treatments for metabolic and inflammatory diseases.

Cassava Sciences

Market Cap: US$157.5m

A clinical stage biotechnology company, develops drugs for neurodegenerative diseases.

Protara Therapeutics

Market Cap: US$157.4m

A clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer and rare diseases.

Achieve Life Sciences

Market Cap: US$157.4m

A late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom.

Scilex Holding

Market Cap: US$157.2m

Focuses on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain.

Avalo Therapeutics

Market Cap: US$152.6m

A clinical stage biotechnology company, focuses on the development of therapies for the treatment of immune dysregulation in the Unites States.

Cybin

Market Cap: US$152.2m

A clinical-stage neuropsychiatry company, focuses on developing psychedelic-based therapeutics for patients with mental health conditions.

Tevogen Bio Holdings

Market Cap: US$152.2m

A clinical-stage specialty immunotherapy company, develops off-the-shelf precision T cell therapies for the treatment of infectious diseases, cancers, and other disorders.

Nuvectis Pharma

Market Cap: US$151.5m

A clinical-stage biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious conditions of unmet medical need in oncology.

Citius Oncology

Market Cap: US$151.2m

Focuses on the development and commercialization of innovative targeted oncology therapies.

Greenwich LifeSciences

Market Cap: US$149.2m

A clinical-stage biopharmaceutical company, develops novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers in the United States and Romania.

Zura Bio

Market Cap: US$148.9m

A clinical-stage biotechnology company, develops medicines for immune and inflammatory disorders in the United States.

Shattuck Labs

Market Cap: US$148.4m

A biotechnology company, develops antibodies for the treatment of inflammatory and immune-mediated diseases.

Climb Bio

Market Cap: US$148.4m

A clinical-stage biotechnology company, focuses on developing therapies for immune-mediated diseases.

Nkarta

Market Cap: US$146.3m

A clinical-stage biopharmaceutical company, develops and commercializes natural killer cell therapies for cancer and autoimmune disease treatment.

Eledon Pharmaceuticals

Market Cap: US$144.9m

Operates as a clinical stage biotechnology company.

Corbus Pharmaceuticals Holdings

Market Cap: US$141.2m

A biopharmaceutical company, develops products to defeat serious illness.

Rapid Micro Biosystems

Market Cap: US$139.7m

A life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally.

Jushi Holdings

Market Cap: US$139.4m

A vertically integrated cannabis company, engages in the cultivation, processing, retail, and distribution of cannabis for the medical and adult-use markets in the United States.

Cardiff Oncology

Market Cap: US$137.7m

A clinical-stage biotechnology company, develops novel therapies for the treatment of various cancers.

biote

Market Cap: US$136.6m

Operates in practice-building business within the hormone optimization space.

Agenus

Market Cap: US$136.1m

A clinical-stage biotechnology company, discovers and develops therapies to activate the body's immune system against cancer and infections in the United States and internationally.

Pyxis Oncology

Market Cap: US$134.6m

A clinical stage company, engages in the development of therapeutics to treat solid tumors.

KALA BIO

Market Cap: US$134.3m

A clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of therapies for rare and severe eye diseases.

Inovio Pharmaceuticals

Market Cap: US$133.9m

A biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases.

Seer

Market Cap: US$132.2m

A life sciences company, develops and commercializes products to decode the biology of the proteome.

Compugen

Market Cap: US$130.9m

A clinical-stage therapeutic discovery and development company, engages in the research, development, and commercialization of therapeutics and product candidates in Israel, the United States, and Europe.

Anika Therapeutics

Market Cap: US$130.8m

A joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, sports medicine, and arthrosurface joint solutions in the United States, Europe, and internationally.

Alpha Cognition

Market Cap: US$129.3m

A biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada.

TuHURA Biosciences

Market Cap: US$128.6m

A clinical stage immuno-oncology company, that develops novel technologies for the treatment of cancer immunotherapies.

Inhibikase Therapeutics

Market Cap: US$128.2m

Operates as a clinical-stage pharmaceutical company that develops therapeutics for Parkinson’s disease and related disorders.

Oncolytics Biotech

Market Cap: US$125.5m

A clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of oncology treatments.

Biomea Fusion

Market Cap: US$122.6m

A clinical-stage diabetes and obesity medicines company, focuses on the discovery and development of oral covalent small molecule drugs to treat patients with metabolic diseases in the United States.

eXoZymes

Market Cap: US$122.5m

Operates as a development stage biotechnology company.

Cognition Therapeutics

Market Cap: US$119.1m

A clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina.